Calibrate

Calibrate

Chronic Disease Management & Digital Therapeutics

About Calibrate

Calibrate is a digital health company specializing in metabolic health and sustainable weight loss through its comprehensive Metabolic Reset program. The company takes a biology-first approach, recognizing that traditional diets fail because sustainable weight loss comes from improving metabolic health rather than calorie counting or willpower alone. Calibrate's program combines three core components: clinician-prescribed GLP-1 medications (such as Wegovy, Ozempic, Mounjaro, Zepbound, and Foundayo), personalized 1:1 video coaching sessions, and a science-backed educational curriculum covering food, exercise, sleep, and emotional health. The program is structured in progressive phases over 12+ months, moving from learning fundamentals to practicing habits to sustaining long-term results. Calibrate serves both individual consumers and employer-sponsored members, with many companies covering the program cost for employees and dependents. The company provides full-service insurance navigation to help members access affordable GLP-1 medications, typically capped at $25/month for those with commercial insurance. With clinically-reviewed results showing members achieve an average of 19% weight loss achieved over three years, Calibrate positions itself as the first and most experienced program built around GLP-1 medications, backed by a 10%+ weight loss guarantee or money-back eligibility.

Clinical Focus

Medical conditions and clinical areas addressed by Calibrate.

ObesityMetabolic health disordersWeight management

Who It Serves

Individual consumersEmployer-sponsored membersHealth plan members

Milestones & Awards

Recent Milestones

Introduced flexible monthly payment model at $199/month (previously may have required larger upfront payment). Expanded GLP-1 medication options to include Foundayo, Zepbound, Wegovy, Ozempic, and Mounjaro.

Awards & Recognition

4.5 average rating from 1,618 reviews. Positioned as first program built around GLP-1 medications.

Key Partnerships

Commercial/employer insurance plansLab testing facilitiesPharmacy networks for GLP-1 medication fulfillment

Company Details

Work here?

Claim this listing to update company information and connect with our audience.

Claim This Listing

Security & Compliance

HIPAA
Last updated Jun 28, 2026

Similar Companies in this Market

View all 46
Abbott Diabetes Care

Abbott Diabetes Care

Abbott Diabetes Care develops FreeStyle Libre, a world-leading continuous glucose monitoring (CGM) portfolio for diabetes management with advanced analytics and innovation.

Amalgam Rx

Amalgam Rx

Amalgam Rx develops AI-powered digital therapeutics and Software as a Medical Device (SaMD) solutions for chronic disease management. The company partners with life sciences companies, health plans, and providers to deliver regulated digital health applications and EHR-integrated clinical decision support tools.

Arkray

Arkray

ARKRAY USA manufactures and distributes blood glucose monitoring systems, clinical diagnostic equipment, and oral wellness products. The company serves consumers with diabetes, healthcare professionals, and clinical laboratories with accurate, affordable diagnostic solutions.

BeatO

BeatO

BeatO is a digital health platform specializing in diabetes management and weight loss solutions. The company offers smart glucose monitoring devices, GLP-1 weight loss programs, and a comprehensive diabetes care program combining connected devices, doctor consultations, and health coaching for over 2 million patients across India.

Brook Health

Brook Health

AI-powered remote patient monitoring and chronic disease management platform for conditions like diabetes, hypertension, and heart disease.

Cadence

Cadence

Cadence delivers AI-powered remote patient care programs for chronic disease management. The company partners with health systems, payers, and medical groups to provide 24/7 monitoring, medication management, and clinical support for patients with hypertension, heart failure, diabetes, and other chronic conditions.

Cala Health

Cala Health

Cala Health develops the Cala kIQ System, an FDA-cleared wearable device that delivers non-invasive neuromodulation therapy for action hand tremor. The device uses transcutaneous afferent patterned stimulation (TAPS) to provide on-demand tremor relief for people with essential tremor and Parkinson's disease.

Cecelia Health

Cecelia Health

Cecelia Health is a national virtual specialty medical practice providing clinician-led integrated cardiometabolic care. The company delivers coordinated treatment for obesity, diabetes, hypertension, chronic kidney disease, and other connected conditions through licensed clinicians including registered dietitians, nurses, and diabetes care specialists.

Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.